In Reply We appreciate the comments Dr Spence made in response to our article1 and the accompanying editorial.2 While our group is convinced by the arguments he has made in the quoted editorial piece regarding the SPARCL (Stroke Prevention by Aggressive Reduction in Cholesterol Levels) trial results, it is important to recognize that controversy does persist in the literature when it comes to this issue.
Flint AC, Rao VA. Statins and Intracerebral Hemorrhage—Reply. JAMA Neurol. 2015;72(2):240–241. doi:10.1001/jamaneurol.2014.4174
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: